|
🐜
|
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
228 auth.
L. Paz-Ares,
M. Dvorkin,
Yuanbin Chen,
N. Reinmuth,
K. Hotta,
D. Trukhin,
G. Statsenko,
M. Hochmair,
M. Özgüroğlu,
J. Ji,
O. Voitko,
A. Poltoratskiy,
Santiago Ponce,
F. Verderame,
L. Havel,
...
I. Bondarenko,
A. Każarnowicz,
G. Losonczy,
N. Conev,
J. Armstrong,
N. Byrne,
N. Shire,
Haiyi Jiang,
J. Goldman,
E. Batagelj,
Ignacio Casarini,
A. V. Pastor,
S. Sena,
J. Zarbá,
O. Burghuber,
S. Hartl,
B. Lamprecht,
M. Studnicka,
L. Schlittler,
Fabricio Augusto Martinelli de Oliveira,
A. Calabrich,
G. Girotto,
P. Reis,
Carlo Gorini,
Peo Rafael Martins De Marchi,
C. Baldotto,
C. Sette,
M. Zukin,
A. Dudov,
R. Ilieva,
K. Koynov,
R. Krasteva,
I. Tonev,
S. Valev,
V. Venkova,
M. Bi,
Chengshui Chen,
Yuan Chen,
Zhendong Chen,
J. Fang,
Jifeng Feng,
Zhigang Han,
Jie Hu,
Yi Hu,
Wei Li,
Zongan Liang,
Zhong Lin,
R. Ma,
Shenglin Ma,
K. Nan,
Y. Shu,
Kai Wang,
Mengzhao Wang,
Gang Wu,
N. Yang,
Zhi-Xiong Yang,
He-long Zhang,
Wei Zhang,
Jun Zhao,
Yanqiu Zhao,
Caicun Zhou,
Jianying Zhou,
Xiang-dong Zhou,
V. Kolek,
L. Koubková,
J. Roubec,
J. Skřičková,
M. Zemanova,
C. Chouaid,
W. Hilgers,
H. Léna,
D. Moro-Sibilot,
G. Robinet,
P. Souquet,
J. Alt,
H. Bischoff,
C. Grohé,
E. Laack,
S. Lang,
J. Panse,
C. Schulz,
K. Bogos,
E. Csánky,
Anea Fülöp,
Z. Horváth,
Judit Kósa,
I. Laczó,
G. Pajkos,
Z. Pápai,
Zsolt Pápai Székely,
V. Sárosi,
A. Somfay,
É. Ezer,
Anás Telekes,
J. Bar,
M. Gottfried,
N. Heching,
Alona Zer Kuch,
R. Bartolucci,
A. Bettini,
A. Delmonte,
M. Garassino,
M. Minelli,
F. Roila,
S. Atagi,
K. Azuma,
H. Goto,
K. Goto,
Yu Hara,
H. Hayashi,
T. Hida,
Kenya Kanazawa,
S. Kanda,
Y. H. Kim,
S. Kuyama,
T. Maeda,
M. Morise,
Y. Nakahara,
M. Nishio,
N. Nogami,
I. Okamoto,
H. Saito,
M. Shinoda,
S. Umemura,
T. Yoshida,
N. Claessens,
R. Cornelissen,
Lizza Heniks,
Jeroen Hiltermann,
E. Smit,
A. J. S. D. Brekel,
D. Kowalski,
S. Mańdziuk,
Robert Mróz,
M. Wojtukiewicz,
T. Ciuleanu,
D. Ganea,
A. Ungureanu,
A. Luft,
V. Moiseenko,
D. Sakaeva,
A. Smolin,
Alexander Vasilyev,
L. Vladimirova,
Igor Anasina,
J. Chovanec,
P. Demo,
R. Godal,
P. Kasan,
M. Stresko,
M. Urda,
E. Cho,
Joo‐Hang Kim,
Sang-We Kim,
Gyeong-Won Lee,
Jong-Seok Lee,
K. Lee,
K. Lee,
Yun-Gyoo Lee,
M. Molla,
M. D. Gómez,
J. I. D. Mingorance,
D. Casado,
M. L. Brea,
M. M. Tarruella,
T. M. Bueno,
A. N. Mendivil,
Luis Paz-Ares Rodríguez,
S. P. Aix,
M. Campelo,
G. Chang,
Yen-Hsun Chen,
C. Chiu,
T. Hsia,
Kang-Yun Lee,
Chien-Te Li,
Chin-Chou Wang,
Yu-Feng Wei,
Shang‐Yin Wu,
A. Alacacıoğlu,
I. Çiçin,
A. Demirkazık,
M. Erman,
T. Göksel,
H. Adamchuk,
O. Kolesnik,
A. Kryzhanivska,
Y. Ostapenko,
S. Shevnia,
Y. Shparyk,
G. Ursol,
N. Voitko,
I. Vynnychenko,
S. Babu,
A. Chiang,
W. Chua,
S. Dakhil,
A. Dowlati,
Basir Haque,
Rodney Jamil,
J. Knoble,
Shailena Lakhanpal,
Kailhong Mi,
P. Nikolinakos,
S. Powell,
H. Ross,
E. Schaefer,
J. Schneider,
Joseph E. Spahr,
D. Spigel,
J. Stilwill,
C. Sumey,
Michael Williamson
|
10 |
2019 |
10
🐜
|
|
🐜
|
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
263 auth.
Jonathan D Spicer,
M. Garassino,
Heather A. Wakelee,
Moishe Liberman,
T. Kato,
Masahiro Tsuboi,
Se-Hoon Lee,
Kevin Chen,
C. Dooms,
M. Majem,
E. Eigendorff,
G. Martinengo,
O. Bylicki,
D. Rodríguez-Abreu,
J. Chaft,
...
S. Novello,
Jing Yang,
A. Arunachalam,
S.M. Keller,
A. Samkari,
Shugeng Gao,
S. Afanasyev,
Samreen Ahmed,
Todd Alekshun,
Gustavo Alves,
Ian Anderson,
L.H. Araujo,
A. Arkhipov,
Arvind Arora,
Jie Bai,
Paul Begin,
Aleksandr Belonogov,
H. Bérard,
Radu Berceanu-Ion,
R. B. Caro,
Igor Bondarenko,
Reiner Bonnet,
Joaquim Bosch Barrera,
Carlos Brocca,
Maciej Bryl,
Alessandra Bulotta,
A. C. Blanco,
E. Carcereny,
Leticia Carvalho,
C. Cebotaru,
J. Chaft,
V. Charu,
Fabio Chaves,
Jun Chen,
Haiquan Chen,
Qixun Chen,
Kevin Chen,
C. Chiang,
Chao-Hua Chiu,
S. Cicėnas,
Elena Ciubotaru,
T. Ciuleanu,
Ioana Ciurescu,
Patrick Cobb,
Corlia Coetzee,
Dearbhaile Collins,
D. Cortinovis,
Kimberly Costas,
Dan Costin,
E. Cronemberger,
Raymund Cuevo,
S. Cuffe,
P. Marchi,
Tadeu de Paiva Junior,
A. Delmonte,
I. Demedts,
K. Deschepper,
Josiane Dias,
B. Duchemann,
Carolina Dutra,
H. Duvivier,
Vinicius Ernani,
M. Faehling,
Luiza Faria,
Alexander Fedenko,
Hiran Fernando,
Roberto Ferrara,
Vittorio Ferrari,
Gene Finley,
P. Fix,
M.B. Flores,
S. Fourie,
Fabio A. Franke,
Klaus-Peter Frohling,
Muhammad Furqan,
Cristian Gal,
Robert Galamaga,
D. Ganea,
A. Ganti,
M. Garassino,
R. Gentzler,
Luca Gianni,
M. Gilli,
N. Girard,
Bojidar Goranov,
V. Gregorc,
A. Greystoke,
Salvatore Grisanti,
Christian Grohé,
Michael Guarino,
Jose Luiz Guimaraes,
F. Guisier,
Bal'azs P. Halmos,
Z. Hammoud,
Ji-Youn Han,
A. Hegmane,
Fook Yew Heng,
H. Horinouchi,
Y. Horio,
Jian Hu,
Hsu-Ching Huang,
R. Hui,
Norihiko Ikeda,
S. Intagliata,
Ingrid Iordan,
C. Jacobs,
Kirti Jain,
Sushil Jain,
Tao Jiang,
N. Karaseva,
P. Kaywin,
Shayma Kazmi,
R. Keresztes,
Sarah Khan,
Jhingook Kim,
Olena Kolesnik,
O. Kolesnik,
J. Kollmeier,
Takefumi Komiya,
Michael Koontz,
Yuliia Krasnohrud,
Timothy Kristedja,
A. Kryzhanivska,
H. Kuroda,
K. Laktionov,
M. Lambrechts,
S. Lang,
A. Langleben,
M. Lehmann,
E. Levchenko,
Oleh Levenko,
Shanqing Li,
Bin-Chi Liao,
I. Lima,
Geoffrey Liu,
Theresa Liu-Dumlao,
G. Russo,
Yan Yan Lou,
A. Lowczak,
Alexander Luft,
Shaohua Ma,
M. M. Tarruella,
Krytsyna Makles,
G. Martinengo,
A. Marti,
Danielli Matias,
J. Mazières,
L. Mazilu,
B. Mennecier,
M. Migliorino,
J. Misleh,
Julian Molina,
I. Morbeck,
Annette Mueller,
S. Muto,
Ernest Nadal Alforja,
Alfiya Nesterova,
Wataru Nishio,
Jiaxin Niu,
M.E.R. O'Brien,
Steven O'Day,
F. Ogliari,
Morihito Okada,
Yong Kek Pang,
Viktor Paramonov,
A. Pastor,
Ireneusz Pawlak,
F. Piantedosi,
Theodore Pollock,
Tony Pope,
J.M. Puig,
S. Radhi,
Suman Rao,
C. Rathnasabapathy,
M. Reck,
A. Reinacher-Schick,
Patricia Rich,
Mathias Ritgen,
A. Rittmeyer,
Elisa Roca,
D. Rodríguez-Abreu,
Paul Ruff,
Igor Rybkin,
H. Saji,
Yukinori Sakao,
A. Sangal,
A. Santoro,
Rodrigo Sardenberg,
P. Savvides,
R. Scheusan,
Joan H. Schiller,
Lana Schumacher,
M. Serke,
Byoung Yong Shim,
J. Shimizu,
Y. Shio,
A. Sibille,
Robert Siegel,
D. Signorelli,
Maria Smagina,
Iryna Sokur,
Jonathan D Spicer,
Gordan Srkalovic,
L. Stampleman,
A. Starodub,
K. Stencel,
Kenji Sugio,
V. Surmont,
Hiroyuki Suzuki,
J. Tabacof,
K. Takamochi,
Lijie Tan,
Fumihiro Tanaka,
M. Tatangelo,
D. Täuscher,
Carlos Teixeira,
Luc Thiberville,
D. Trukhin,
Chen-Liang Tsai,
A. Ungureanu,
G. Ursol,
T. Vanakesa,
Johan F. Vansteenkiste,
M. Varela,
M. Villalona-Calero,
L. Villaruz,
Gunther Vogel,
Nataliia Voitko,
Qun Wang,
Wenxiang Wang,
Chin-Chou Wang,
Sarah Wang,
T. Wehler,
Benny Weksler,
M. Wermke,
C. Wesseler,
Hubert Wirtz,
Mark Wong,
Xiaolong Yan,
Yue Yang,
Kong Leong Yu,
X. Zasadny,
Marius Žemaitis,
Lanjun Zhang,
Guofang Zhao,
Qing Zhao,
Yuming Zhu,
B. Żurawski
|
3 |
2024 |
3
🐜
|
|
🐜
|
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer.
21 auth.
Carlotta Keunecke,
H. Kulbe,
Felix Dreher,
E. Taube,
R. Chekerov,
D. Horst,
M. Hummel,
T. Kessler,
K. Pietzner,
Wanja Kassuhn,
...
F. Heitz,
M. Muallem,
S. Lang,
I. Vergote,
O. Dorigo,
H. Lammert,
A. du Bois,
Tim Angelotti,
C. Fotopoulou,
J. Sehouli,
E. Braicu
|
2 |
2022 |
2
🐜
|
|
🐜
|
Nintedanib plus docetaxel in routine clinical practice: VARGADO, a German prospective non-interventional study (NIS) reflecting routine treatment conditions in an evolving NSCLC treatment landscape.
13 auth.
C. Grohé,
I. Zander,
K. Lüdtke-Heckenkamp,
W. Blau,
Stefan Krüger,
C. Franke,
H. Mueller-Huesmann,
W. Brückl,
N. Basara,
D. Ukena,
...
S. Lang,
J. Atz,
Roselinde H. Kaiser
|
0 |
2018 |
0
🐜
|
|
🦁
|
P27 Patterns of care and predictors of overall survival in women diagnosed with serous tubal intra-epithelial carcinoma (STIC)
S. Lang,
S. Crafton,
E. Miller,
T. Krivak,
Z. Horne
|
0 |
2023 |
0
🦁
|
|
🐜
|
Bevacizumab (Avastin) in Combination with Platinum-Based Chemotherapy as First-Line Therapy for Advanced Non-Small Cell Lung Cancer in Different Age Groups in Germany
7 auth.
H. Wirtz,
S. Lang,
C. Gessner,
S. Krüger,
M. Zortel,
S. Heinzmann,
...
W. Schütte
|
0 |
2020 |
0
🐜
|
|
🐜
|
Bevacizumab in routine clinical practice for first-line therapy with platinum-based chemotherapy of patients with advanced adenocarcinoma of the lung in Germany
10 auth.
H. Wirtz,
S. Lang,
J. Mezger,
S. Hammerschmidt,
T. Gaska,
C. Lerchenmueller,
...
M. Reck,
S. Haas,
D. Reichert,
G. Hoeffken
|
0 |
2016 |
0
🐜
|
